SEATTLE, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BIO VENTURES FOR GLOBAL HEALTH, founded in 2003, is a community nonprofit in the Health Care sector that reported $4.7M in total revenue in fiscal year 2023. Revenue surged 139% from the prior year, signaling strong growth momentum. The organization ran a surplus of $2.3M, a strong 48% operating margin.
BVGH CONNECTS PEOPLE, RESOURCES, AND IDEAS ACROSS BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, GOVERNMENTS, AND NONPROFITS TO SOLVE GLOBAL HEALTH ISSUES.
THE GLOBAL INNOVATION ALLIANCE PROGRAM (GIA) TARGETS INFECTIOUS DISEASES BURDENSOME IN LOW-AND MIDDLE-INCOME COUNTRIES (LMICS) BY FORGING PUBLIC-PRIVATE PARTNERSHIPS THAT ADVANCE RESEARCH, BUILD...
THE GLOBAL INNOVATION ALLIANCE PROGRAM (GIA) TARGETS INFECTIOUS DISEASES BURDENSOME IN LOW-AND MIDDLE-INCOME COUNTRIES (LMICS) BY FORGING PUBLIC-PRIVATE PARTNERSHIPS THAT ADVANCE RESEARCH, BUILD SCIENTIFIC CAPACITY, PROMOTE CLINICAL TRIAL INCLUSION, AND COMMUNICATE SUCCESSES. GIA HAS SERVED MORE THAN 100 SCIENTISTS IN LMICS.
THE AFRICAN ACCESS INITIATIVE (AAI) IS A PPP THAT TARGETS THE CANCER CRISIS IN AFRICA. THROUGH AAI, BVGH IS STRENGTHENING HEALTHCARE SYSTEMS, BUILDING ONCOLOGY CAPACITY AND SKILLS, FORGING RESEARCH...
THE AFRICAN ACCESS INITIATIVE (AAI) IS A PPP THAT TARGETS THE CANCER CRISIS IN AFRICA. THROUGH AAI, BVGH IS STRENGTHENING HEALTHCARE SYSTEMS, BUILDING ONCOLOGY CAPACITY AND SKILLS, FORGING RESEARCH AND DEVELOPMENT PARTNERSHIPS LED BY AFRICAN HEALTHCARE PROFESSIONALS, BUILDING AND PROMOTING CLINICAL TRIAL READINESS, AND CREATING COMMUNITY AWARENESS AND PROMOTING HEALTH EDUCATION. AAI HAS TRAINED MORE THAN 18,000 ONCOLOGY HEALTHCARE PROFESSIONALS, DELIVERED ACCESS TO MULTIPLE CANCER MEDICINES, AND FORGED COUNTLESS PARTNERSHIPS.
CLINICAL TRIAL DIVERSITY AND EQUITY - BVGH IS CONDUCTING CLINICAL TRIAL TRAINING AND PROFILING AND PROMOTING SITES IN LMICS TO DE-RISK PRIMARY INVESTIGATOR AND SITE SELECTION FOR ACADEMICS AND...
CLINICAL TRIAL DIVERSITY AND EQUITY - BVGH IS CONDUCTING CLINICAL TRIAL TRAINING AND PROFILING AND PROMOTING SITES IN LMICS TO DE-RISK PRIMARY INVESTIGATOR AND SITE SELECTION FOR ACADEMICS AND INDUSTRY. MORE THAN 100 SITES IN LMICS ARE BENEFITING THROUGH BVGH'S PROMOTION AND TRAINING PROGRAMS ACROSS DISEASE AREAS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $4,702,895 | $1,971,687 | +1.4% |
| Expenses | $2,437,035 | $2,227,074 | +0.1% |
| Net Income | $2,265,860 | $-255,387 | -9.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAMES GREENWOOD | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| RUTH ATHERTON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH DAMOND | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JIM GERAGHTY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JULIE GRALOW | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SERIGNE MAGUEYE GUEYE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| J LEIGHTON READ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOHN NEVERGOLE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER DENT | PRESIDENT & CEO | 40.00 |
Officer
Director
|
$405,513 | $49,381 | $454,894 |
| KATY GRAEF | VICE PRESIDENT PROGRAMS | 40.00 |
Key Emp
|
$177,400 | $17,367 | $194,767 |
| CATHYRYNE MANNER | VICE PRESIDENT | 40.00 |
Highest
|
$160,825 | $18,377 | $179,202 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $4,702,895 | $2,437,035 | $7,501,784 | $2,265,860 |
| 2022 | $1,971,687 | $2,227,074 | $5,354,552 | $-255,387 |
| 2021 | $3,211,056 | $2,124,020 | $5,318,274 | $1,087,036 |
| 2020 | $4,396,021 | $1,662,747 | $4,194,099 | $2,733,274 |
| 2019 | $2,120,671 | $1,834,552 | $1,415,465 | $286,119 |
| 2019 | $1,637,421 | $1,841,899 | $1,454,032 | $-204,478 |
Compare BIO VENTURES FOR GLOBAL HEALTH with other nonprofits in Washington and across the country.